Your browser doesn't support javascript.
loading
Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81).
Scherbak, Nikolai N; Kruse, Robert; Nyström, Thomas; Jendle, Johan.
Affiliation
  • Scherbak NN; Life Science Center, Örebro University, School of Science and Technology, Örebro, Sweden.
  • Kruse R; Department of Clinical Research Laboratory, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Nyström T; Inflammatory Response and Infection Susceptibility Center (iRiSC), Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Jendle J; Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset, Stockholm, Sweden.
Diabetes Metab J ; 47(6): 882-883, 2023 11.
Article in En | MEDLINE | ID: mdl-38043784
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: MicroRNAs / Diabetes Mellitus, Type 2 Limits: Humans Language: En Journal: Diabetes Metab J Year: 2023 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: MicroRNAs / Diabetes Mellitus, Type 2 Limits: Humans Language: En Journal: Diabetes Metab J Year: 2023 Document type: Article Affiliation country: